Galectin Therapeutics Inc. (GALT) quarterly balance sheet — complete assets, liabilities & equity history
| Total Current Assets | 15.69M | 19.44M | 12.73M | 15.43M | 9.29M | 17.25M | 28.67M | 27.29M | 25.46M | 27.71M | 21.61M | 19.47M |
| Cash & Short-Term Investments | 14.11M | 17.72M | 11.53M | 13.77M | 7.43M | 15.12M | 27.06M | 25.6M | 23.55M | 25.66M | 20.36M | 17.97M |
| Cash Only | 14.11M | 17.72M | 11.53M | 13.77M | 7.43M | 15.12M | 27.06M | 25.6M | 23.55M | 25.66M | 20.36M | 17.97M |
| Short-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accounts Receivable | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Sales Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Inventory | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Days Inventory Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Other Current Assets | 1.58M | 1.72M | 1.2M | 1.66M | 1.85M | 2.13M | 1.61M | 0 | 1.91M | 2.05M | 1.25M | 1.5M |
| Total Non-Current Assets | 68K | 96K | 136K | 175K | 243K | 243K | 306K | 368K | 430K | 490K | 552K | 613K |
| Property, Plant & Equipment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 35K | 45K | 53K | 62K | 70 |
| Fixed Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Goodwill | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long-Term Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 68K | 96K | 136K | 175K | 243K | 243K | 306K | 333K | 385K | 437K | 490K | 612.93K |
| Total Assets | 15.76M | 19.53M | 12.87M | 15.6M | 9.53M | 17.5M | 28.97M | 27.66M | 25.89M | 28.2M | 22.16M | 20.08M |
| Asset Turnover | - | - | - | - | - | - | - | - | - | - | - | - |
| Asset Growth % | 65.4% | 11.64% | -55.6% | -43.58% | -63.2% | -37.96% | 30.72% | 37.72% | 28.01% | 32.49% | 23.72% | -22.43% |
| Total Current Liabilities | 7.31M | 8.03M | 136.44M | 10.77M | 110.84M | 35.41M | 25.26M | 14.62M | 12.63M | 15.68M | 10.52M | 9.95M |
| Accounts Payable | 3.12M | 3.25M | 5.39M | 5.87M | 6.53M | 5.66M | 2.79M | 3.7M | 3.8M | 6.43M | 2.68M | 1.98M |
| Days Payables Outstanding | - | - | - | - | - | - | - | - | - | - | - | - |
| Short-Term Debt | 6K | 0 | 122.28M | 0 | 97.11M | 21.12M | 10.52M | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Current) | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 4.18M | 4.7M | 4.84M | 844K | 852K | 1.89M | 1.42M | 63K | 518K | 8.07M | 857K | 7.29M |
| Current Ratio | 2.15x | 2.42x | 0.09x | 1.43x | 0.08x | 0.49x | 1.13x | 1.87x | 2.02x | 1.77x | 2.05x | 1.96x |
| Quick Ratio | 2.15x | 2.42x | 0.09x | 1.43x | 0.08x | 0.49x | 1.13x | 1.87x | 2.02x | 1.77x | 2.05x | 1.96x |
| Cash Conversion Cycle | - | - | - | - | - | - | - | - | - | - | - | - |
| Total Non-Current Liabilities | 138.69M | 137.7M | 1.72M | 122M | 10.95M | 85.16M | 96.19M | 95.19M | 84.34M | 72.77M | 62.51M | 61.26M |
| Long-Term Debt | 135.71M | 133.74M | 0 | 120.46M | 10.81M | 85.11M | 94.04M | 93.42M | 82.46M | 71.74M | 61.14M | 60.36M |
| Capital Lease Obligations | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 7K | 20K | 32K | 0 |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities | 2.98M | 3.96M | 1.72M | 1.54M | 136K | 47K | 2.16M | 1.76M | 1.87M | 1M | 1.34M | 896K |
| Total Liabilities | 146M | 145.73M | 138.17M | 132.77M | 121.79M | 120.56M | 121.45M | 109.8M | 96.98M | 88.44M | 73.04M | 71.21M |
| Total Debt | 135.71M | 133.74M | 122.31M | 120.51M | 107.99M | 106.25M | 104.59M | 93.47M | 82.52M | 71.81M | 61.22M | 60.4M |
| Net Debt | 121.6M | 116.02M | 110.79M | 106.74M | 100.56M | 91.13M | 77.53M | 67.87M | 58.96M | 46.15M | 40.85M | 42.44M |
| Debt / Equity | - | - | - | - | - | - | - | - | - | - | - | - |
| Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Net Debt / EBITDA | - | - | - | - | - | - | - | - | - | - | - | - |
| Interest Coverage | -2.05x | -1.84x | -3.50x | -3.12x | -4.52x | -5.94x | -6.51x | -8.75x | -9.92x | -10.80x | -11.49x | -13.02x |
| Total Equity | -130.24M | -126.19M | -125.3M | -117.17M | -112.26M | -103.07M | -92.48M | -82.15M | -71.09M | -60.24M | -50.87M | -51.13M |
| Equity Growth % | -16.01% | -22.44% | -35.49% | -42.63% | -57.92% | -71.1% | -81.79% | -60.67% | -66.69% | -87.12% | -127.77% | -235.85% |
| Book Value per Share | -1.98 | -1.97 | -1.95 | -1.85 | -1.78 | -1.64 | -1.48 | -1.32 | -1.15 | -1.00 | -0.85 | -0.86 |
| Total Shareholders' Equity | -130.24M | -126.19M | -125.3M | -117.17M | -112.26M | -103.07M | -92.48M | -82.15M | -71.09M | -60.24M | -50.87M | -51.13M |
| Common Stock | 65K | 65K | 64K | 63K | 63K | 62K | 62K | 62K | 61K | 61K | 61K | 59K |
| Retained Earnings | -437.61M | -432.55M | -426.98M | -418.76M | -411.18M | -401.57M | -389.54M | -378.3M | -365.87M | -354.37M | -344.31M | -330.27M |
| Treasury Stock | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -61K | 0 | -510K |
| Minority Interest | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |